Improving ART programme retention and viral suppression are key to maximising impact of treatment as prevention – a modelling study

McCreesh, N.; Andrianakis, I.; Nsubuga, R.; Strong, M.; Vernon, I.; McKinley, T.J.; Oakley, J.E.; Goldstein, M.; Hayes, R.; White, R.G.

Abstract

Background UNAIDS calls for fewer than 500,000 new HIV infections/year by 2020, with treatment-as-prevention being a key part of their strategy for achieving the target. A better understanding of the contribution to transmission of people at different stages of the care pathway can help focus intervention services at populations where they may have the greatest effect. We investigate this using Uganda as a case study. Methods An individual-based HIV/ART model was fitted using history matching. 100 model fits were generated to account for uncertainties in sexual behaviour, HIV epidemiology, and ART coverage up to 2015 in Uganda. A number of different ART scale-up intervention scenarios were simulated between 2016 and 2030. The incidence and proportion of transmission over time from people with primary infection, post-primary ART-naïve infection, and people currently or previously on ART was calculated. Results In all scenarios, the proportion of transmission by ART-naïve people decreases, from 70% (61%–79%) in 2015 to between 23% (15%–40%) and 47% (35%–61%) in 2030. The proportion of transmission by people on ART increases from 7.8% (3.5%–13%) to between 14% (7.0%–24%) and 38% (21%–55%). The proportion of transmission by ART dropouts increases from 22% (15%–33%) to between 31% (23%–43%) and 56% (43%–70%). Conclusions People who are currently or previously on ART are likely to play an increasingly large role in transmission as ART coverage increases in Uganda. Improving retention on ART, and ensuring that people on ART remain virally suppressed, will be key in reducing HIV incidence in Uganda.

Citation

McCreesh, N., Andrianakis, I., Nsubuga, R., Strong, M., Vernon, I., McKinley, T., …White, R. (2017). Improving ART programme retention and viral suppression are key to maximising impact of treatment as prevention – a modelling study. BMC Infectious Diseases, 17(1), Article 557. https://doi.org/10.1186/s12879-017-2664-6

• Journal Article Type: Article
• Acceptance Date: Aug 1, 2017
• Online Publication Date: Aug 9, 2017
• Publication Date: Aug 9, 2017
• Deposit Date: Aug 22, 2016
• Publicly Available Date: Aug 23, 2017
• Journal: BMC Infectious Diseases
• Publisher: BioMed Central
• Peer Reviewed: Peer Reviewed
• Volume: 17
• Issue: 1
• Article Number: 557
• DOI: https://doi.org/10.1186/s12879-017-2664-6
• Public URL: https://durham-repository.worktribe.com/output/1375986